Cargando…

Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view

Children show a higher incidence of leukaemia compared with young adolescents, yet their cells are less damaged because of their young age. Children with Down syndrome (DS) have an even higher risk of developing leukaemia during the first years of life. The presence of a constitutive trisomy of chro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasaart, K. A. L., Bertrums, E. J. M., Manders, F., Goemans, B. F., van Boxtel, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086399/ https://www.ncbi.nlm.nih.gov/pubmed/33902785 http://dx.doi.org/10.1017/erm.2021.6

Ejemplares similares

Mutation accumulation and developmental lineages in normal and Down syndrome human fetal haematopoiesis
por: Hasaart, Karlijn A. L., et al.
Publicado: (2020)

The Dynamics of Somatic Mutagenesis During Life in Humans
por: Manders, Freek, et al.
Publicado: (2021)

Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group
por: Canfield, K N, et al.
Publicado: (2004)

The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
por: de Castro, Carini Picardi Morais, et al.
Publicado: (2021)

Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis
por: Osorio, Fernando G., et al.
Publicado: (2018)

Acute leukaemia in children with Down syndrome in a low middle-income country
por: Ul-Ain, Rahat, et al.
Publicado: (2022)

Breastfeeding and early infection in the aetiology of childhood leukaemia in Down syndrome
por: Flores-Lujano, J, et al.
Publicado: (2009)

Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia
por: Núñez-Enríquez, J C, et al.
Publicado: (2013)

Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
por: Brandsma, Arianne M., et al.
Publicado: (2021)

Megakaryoblasts in pleural fluid in neonate with transient leukaemia of Down's syndrome
por: Chmielowiec, Karolina, et al.
Publicado: (2023)

Reply: Comment on ‘Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter-Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)' – A reality or myth or two viewpoints about the association between allergies and acute leukaemia in Down syndrome children
por: Núñez-Enríquez, J C, et al.
Publicado: (2013)

Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo
por: Hasaart, Karlijn A.L., et al.
Publicado: (2022)

Mutation accumulation in mtDNA of cancers resembles mutagenesis in normal stem cells
por: Manders, Freek, et al.
Publicado: (2022)

Usp16 contributes to somatic stem cell defects in Down syndrome
por: Adorno, Maddalena, et al.
Publicado: (2013)

Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
por: Bertrums, Eline J.M., et al.
Publicado: (2022)

Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
por: Li, Yilong, et al.
Publicado: (2014)

BAG1 down‐regulation increases chemo‐sensitivity of acute lymphoblastic leukaemia cells
por: Mariotto, Elena, et al.
Publicado: (2021)

Group Changes in Cortisol and Heart Rate Variability of Children with Down Syndrome and Children with Autism Spectrum Disorder during Dog-Assisted Therapy
por: Griffioen, Richard E., et al.
Publicado: (2023)

Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients
por: de Kanter, Jurrian K., et al.
Publicado: (2021)

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union
por: van Beek, Dianne, et al.
Publicado: (2013)

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
por: Bertrums, Eline J.M., et al.
Publicado: (2021)

P1316: ASSESSING GENOMIC SAFETY OF ANTIVIRAL NUCLEOSIDE ANALOGS IN HEMATOPOIETIC STEM CELLS
por: Peci, F., et al.
Publicado: (2022)

Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia
por: Goemans, Bianca F., et al.
Publicado: (2021)

Comment on ‘Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)' – Is increased surveillance by hypersensitive immune system a reality or myth?
por: Aryan, Z, et al.
Publicado: (2013)

The Mortality from Leukaemia and Other Cancers Among Patients with Down's Syndrome (Mongols) and Among their Parents*
por: Holland, W. W., et al.
Publicado: (1962)

Down Syndrome, Increased Risk of Dementia and Lipid Disturbances
por: Kłosowska, Anna, et al.
Publicado: (2017)

Somatic evolutionary timings of driver mutations
por: Gomez, Karen, et al.
Publicado: (2018)

Single cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
por: Potter, N, et al.
Publicado: (2018)

Increased levels of anti-BSA antibodies in children with Down syndrome
por: Grace, Sian L., et al.
Publicado: (2023)

Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2022)

Increased risk of venous thromboembolism in patients with acute leukaemia
por: Mohren, M, et al.
Publicado: (2006)

A transcriptional view on somatic embryogenesis
por: Horstman, Anneke, et al.
Publicado: (2017)

Healthy Growth in Children with Down Syndrome
por: Van Gameren-Oosterom, Helma B. M., et al.
Publicado: (2012)

Gene modification therapies: Views of parents of people with Down syndrome
por: Michie, Marsha, et al.
Publicado: (2018)

Parental views on plastic surgery for Down syndrome: an African perspective
por: Michael, Afieharo Igbibia, et al.
Publicado: (2019)

Whole-genome sequencing and mutational analysis of human cord-blood derived stem and progenitor cells
por: Rosendahl Huber, Axel, et al.
Publicado: (2022)

Leukæmia
por: Kaupp, B. F.
Publicado: (1899)

Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications
por: Batlle-Masó, Laura, et al.
Publicado: (2022)

Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
por: Michels, Naomi, et al.
Publicado: (2021)

Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism
por: Iourov, Ivan Y., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4nbeevale0a7knjd19hf9qi8ig